Target of the Week - HER2 (ErbB2) Antibodies

|
Dear Cancer Researcher, Abgent offers a portfolio of antibodies for the detection of HER2 (ErbB2) in western blotting, immunohistochemistry and immunofluorescence. HER2 proteins have been shown to form clusters in cell membranes that may play a role in tumorigenesis. Amplification and/or overexpression of the HER2 gene have been reported in numerous cancers, including breast and ovarian tumors. To find the right antibody for your research, please visit Abgent HER2 (ErbB2) Antibodies. |
Phospho-ERBB2 (T1172) PolyclonalAntibody Cat# AP3781h |
Polyclonal ERBB2 AntibodyCat# AP7629e |
Pospho-ERBB2 (Y1127) AntibodyCat# AP3781j |
Pospho-ERBB2 (T1166) AntibodyCat# AP3781g |
![]() |
![]() |
![]() |






Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.


